SLONKOVÁ, Veronika, Veronika Jr. SLONKOVÁ, Anna VAŠKŮ and Vladimír VAŠKŮ. Genetic predisposition for chronic venous insufficiency in several genes for matrix metalloproteinases (MMP-2, MMP-9, MMP-12) and their inhibitor TIMP-2. Journal of the European Academy of Dermatovenereology. Hoboken: Wiley-Blackwell, 2017, vol. 31, No 10, p. 1746-1752. ISSN 0926-9959. Available from: https://dx.doi.org/10.1111/jdv.14447.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Genetic predisposition for chronic venous insufficiency in several genes for matrix metalloproteinases (MMP-2, MMP-9, MMP-12) and their inhibitor TIMP-2
Authors SLONKOVÁ, Veronika (203 Czech Republic, guarantor, belonging to the institution), Veronika Jr. SLONKOVÁ (203 Czech Republic), Anna VAŠKŮ (203 Czech Republic, belonging to the institution) and Vladimír VAŠKŮ (203 Czech Republic, belonging to the institution).
Edition Journal of the European Academy of Dermatovenereology, Hoboken, Wiley-Blackwell, 2017, 0926-9959.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30216 Dermatology and venereal diseases
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 4.287
RIV identification code RIV/00216224:14110/17:00099676
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1111/jdv.14447
UT WoS 000413582400055
Keywords (in Czech) venózní insuficience, MMP; TIMP
Keywords in English Venous insufficiency; MMP; TIMP
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 20/3/2018 15:25.
Abstract
OBJECTIVE: The project was scheduled as a case-control study to investigate the correlation between MMP-2 (rs243864), MMP-9 (3918242), MMP-12 (rs7123600) and TIMP-2 (rs8176329) polymorphisms and chronic venous disease (CVD) risk. The genotype and phenotype research envisages the testing of possible associations between MMP and TIMP-2 genotypes and phenotypes of CVD. MATERIAL AND METHODS: 150 patients with CVD and 227 controls were enrolled into the study. The MMPs and TIMP-2 genotypes were identified by the PCR method and restriction analysis according to standard protocols. RESULTS: The G allele of MMP-2 -790 T/G was 1.85 times more frequent in men with CVD than in the control group (P = 0.008). The T allele of MMP-9 -1562 C/T was observed 2.571 times more frequently in patients with CVD than in the control individuals (both in men and women) with clinically significant specificity (P = 0.0000009). The G allele of MMP-12 rs7123600 was determined 2.082 times more frequently in female patients with CVD than in the control group with clinically significant specificity (P = 0.02). No significant result in TIMP-2 rs8176329 polymorphism in the case-control study was observed. CVD women with G allele in MMP-2 -790 T/G in the genotype-phenotype study are seen to develop ulceration 2.539 times more frequently (P = 0.003). The G allele of MMP-12 rs7123600 was detected 3.167 times more frequently in CVD women with ulceration compared with CVD women without ulceration (P = 0.007). In CVD men in C6 stage, the incidence of AG genotype in rs7123600 MMP-12 polymorphism was found to be 4.675 times higher compared to CVD women with C6 staging (P = 0.005). The AG genotype in TIMP 2 rs8176329 polymorphism was found to be associated with higher risk of tumour (P = 0.01). CONCLUSION: Studying these polymorphisms can contribute to better identification of patients at higher risk of developing CVD, while providing the most appropriate prevention and treatment strategies.
Links
MUNI/A/1401/2016, interní kód MUName: Patofyziologické biomarkery u komplexních nemocí (Acronym: Biomarkery)
Investor: Masaryk University, Category A
MUNI/A/1420/2016, interní kód MUName: Hodnocení diagnostických a terapeutických metod u pacientů s vybranými kožními nemocemi (Acronym: Genetika, světloléčba)
Investor: Masaryk University, Category A
PrintDisplayed: 25/4/2024 19:11